Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.03p
   
  • Change Today:
      0.025p
  • 52 Week High: 12.50
  • 52 Week Low: 1.98
  • Currency: UK Pounds
  • Shares Issued: 782.06m
  • Volume: 632,383
  • Market Cap: £15.84m

STX Overview

Shield is a de-risked commercial stage, pharmaceutical company focused on addressing iron deficiency in adults with or without anaemia. Our clear purpose is to develop products that help patients become people again, enabling them to enjoy the things that make a difference in their everyday lives.

Key Personnel

Group Chief Executive: Greg Madison
Independent Non-Executive Director: Peter Llewellyn-Davies
Independent Non-Executive Director: Anders Lundstrom
Independent Non-Executive Director: Fabiana Lacerca Allen
Non-Executive Chairman: Hans-Peter Hasler
Non-Executive Dir: Christian Schweiger

Contact Details

Address: Northern Design Centre, Baltic Business Quarter, Gateshead Quays, United Kingdom, NE8 3DF
Phone: +44 (0) 191 511 8500
Website: http://www.shieldtherapeutics.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BYV81293

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

STX Market Data

Currency UK Pounds
Share Price 2.03p
Change Today 0.025p
% Change 1.25 %
52 Week High 12.50
52 Week Low 1.98
Volume 632,383
Shares Issued 782.06m
Market Cap £15.84m

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
48.28% below the market average48.28% below the market average48.28% below the market average48.28% below the market average48.28% below the market average
37.04% above the sector average37.04% above the sector average37.04% above the sector average37.04% above the sector average37.04% above the sector average
Price Trend
94.74% below the market average94.74% below the market average94.74% below the market average94.74% below the market average94.74% below the market average
89.47% below the sector average89.47% below the sector average89.47% below the sector average89.47% below the sector average89.47% below the sector average
Income Not Available
Growth
57.48% above the market average57.48% above the market average57.48% above the market average57.48% above the market average57.48% above the market average
72.97% above the sector average72.97% above the sector average72.97% above the sector average72.97% above the sector average72.97% above the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
16:22 4,500 @ 2.05p
15:40 200 @ 2.05p
15:40 487 @ 2.05p
15:36 30,000 @ 2.03p
15:33 4,357 @ 1.99p

Top of Page